Motsinger-Reif AA - Search Results

1

Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial.

Morieri ML, Gao H, Pigeyre M, Shah HS, Sjaarda J, Mendonca C, Hastings T, Buranasupkajorn P, Motsinger-Reif AA, Rotroff DM, Sigal RJ, Marcovina SM, Kraft P, Buse JB, Wagner MJ, Gerstein HC, Mychaleckyj JC, Parè G, Doria A. Morieri ML, et al. Diabetes Care. 2018 Nov;41(11):2404-2413. doi: 10.2337/dc18-0709. Epub 2018 Sep 27. Diabetes Care. 2018. PMID: 30262460 Free PMC article. Clinical Trial.

2

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs.

Peters EJ, Motsinger-Reif A, Havener TM, Everitt L, Hardison NE, Watson VG, Wagner M, Richards KL, Province MA, McLeod HL. Peters EJ, et al. Pharmacogenomics. 2011 Oct;12(10):1407-15. doi: 10.2217/pgs.11.92. Pharmacogenomics. 2011. PMID: 22008047 Free PMC article.

3

Clinical trial evidence of the promise of pharmacogenomics warfarin dosing algorithms.

Motsinger-Reif AA, Wagner MJ. Motsinger-Reif AA, et al. Pharmacogenomics. 2012 Jun;13(8):861-3. doi: 10.2217/pgs.12.65. Pharmacogenomics. 2012. PMID: 22676190 No abstract available.

4

Replication study of CYP4F2 association with warfarin response in an Israeli population.

Motsinger-Reif AA, Wagner MJ. Motsinger-Reif AA, et al. Pharmacogenomics. 2012 Jun;13(8):863-4. Pharmacogenomics. 2012. PMID: 22855976 No abstract available.

5

A new explained-variance based genetic risk score for predictive modeling of disease risk.

Che R, Motsinger-Reif AA. Che R, et al. Stat Appl Genet Mol Biol. 2012 Sep 25;11(4):Article 15. doi: 10.1515/1544-6115.1796. Stat Appl Genet Mol Biol. 2012. PMID: 23023697 Free PMC article.

6

Naturally occuring canine cancers: powerful models for stimulating pharmacogenomic advancement in human medicine.

Rotroff DM, Thomas R, Breen M, Motsinger-Reif AA. Rotroff DM, et al. Pharmacogenomics. 2013 Dec;14(16):1929-31. doi: 10.2217/pgs.13.178. Pharmacogenomics. 2013. PMID: 24279843 No abstract available.

7

Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.

Thomas R, Borst L, Rotroff D, Motsinger-Reif A, Lindblad-Toh K, Modiano JF, Breen M. Thomas R, et al. Chromosome Res. 2014 Sep;22(3):305-19. doi: 10.1007/s10577-014-9406-z. Epub 2014 Mar 6. Chromosome Res. 2014. PMID: 24599718 Free PMC article.

8

Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics.

Hariani GD, Lam ET, Havener T, Kwok PY, McLeod HL, Wagner MJ, Motsinger-Reif AA. Hariani GD, et al. BMC Res Notes. 2014 Jun 12;7:360. doi: 10.1186/1756-0500-7-360. BMC Res Notes. 2014. PMID: 24924344 Free PMC article.

9

Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.

Jack J, Rotroff D, Motsinger-Reif A. Jack J, et al. Curr Mol Med. 2014;14(7):833-40. doi: 10.2174/1566524014666140811113946. Curr Mol Med. 2014. PMID: 25109794 Free PMC article.

10

Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.

Roode SC, Rotroff D, Avery AC, Suter SE, Bienzle D, Schiffman JD, Motsinger-Reif A, Breen M. Roode SC, et al. Chromosome Res. 2015 Dec;23(4):681-708. doi: 10.1007/s10577-015-9475-7. Epub 2015 Jun 3. Chromosome Res. 2015. PMID: 26037708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters